<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33450997</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Mitophagy Modulation, a New Player in the Race against ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">740</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22020740</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative disease that usually results in respiratory paralysis in an interval of 2 to 4 years. ALS shows a multifactorial pathogenesis with an unknown etiology, and currently lacks an effective treatment. The vast majority of patients exhibit protein aggregation and a dysfunctional mitochondrial accumulation in their motoneurons. As a result, autophagy and mitophagy modulators may be interesting drug candidates that mitigate key pathological hallmarks of the disease. This work reviews the most relevant evidence that correlate mitophagy defects and ALS, and discusses the possibility of considering mitophagy as an interesting target in the search for an effective treatment for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Madruga</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7012-9737</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Biol&#xf3;gicas-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maestro</LastName><ForeName>In&#xe9;s</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5026-5803</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Biol&#xf3;gicas-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2707-8110</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Biol&#xf3;gicas-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>H2020-MSCA-ITN-2017 (grant no. 765912)</GrantID><Agency>H2020 Marie Sk&#x142;odowska-Curie Actions</Agency><Country/></Grant><Grant><GrantID>BMD-3813 ELA_Madrid</GrantID><Agency>CAM</Agency><Country/></Grant><Grant><GrantID>PID2019-105600RB-I00</GrantID><Agency>Ministerio de Ciencia, Innovaci&#xf3;n y Universidades</Agency><Country/></Grant><Grant><GrantID>CIBERNED (CB18/05/00040).</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="N">Mitophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">drug target</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mitophagy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33450997</ArticleId><ArticleId IdType="pmc">PMC7828440</ArticleId><ArticleId IdType="doi">10.3390/ijms22020740</ArticleId><ArticleId IdType="pii">ijms22020740</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur K.C., Calvo A., Price T.R., Geiger J.T., Chi&#xf2; A., Traynor B.J. Projected Increase in Amyotrophic Lateral Sclerosis from 2015 to 2040. Nat. Commun. 2016;7:12408. doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Brown R.H. Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb. Perspect. Med. 2018;8:a024125. doi: 10.1101/cshperspect.a024125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic Lateral Sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., Van Den Berg L.H. Amyotrophic Lateral Sclerosis. Nat. Rev. Dis. Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Yellen G. Fueling Thought: Management of Glycolysis and Oxidative Phosphorylation in Neuronal Metabolism. J. Cell Biol. 2018;21:2235&#x2013;2246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028533</ArticleId><ArticleId IdType="pubmed">29752396</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrera-Juli&#xe1; S., Moreno M.L., Barrios C., de la Rubia Ort&#xed; J.E., Drehmer E. Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review. Front. Physiol. 2020;11:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7016185</ArticleId><ArticleId IdType="pubmed">32116773</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., D&#x2019;Ambrosi N., Cozzolino M. Pathways to Mitochondrial Dysfunction in ALS Pathogenesis. Biochem. Biophys. Res. Commun. 2017;483:1187&#x2013;1193. doi: 10.1016/j.bbrc.2016.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.055</ArticleId><ArticleId IdType="pubmed">27416757</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B., Li&#xe9;vens J.C. Mitochondrial Quality Control in Amyotrophic Lateral Sclerosis: Towards a Common Pathway? Neural Regen. Res. 2017;12:1052&#x2013;1061. doi: 10.4103/1673-5374.211179.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.211179</ArticleId><ArticleId IdType="pmc">PMC5558479</ArticleId><ArticleId IdType="pubmed">28852382</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C., Petrucelli L. Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS. Neuron. 2019;101:1057&#x2013;1069. doi: 10.1016/j.neuron.2019.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.032</ArticleId><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Chapman A.L., Tennant M.E., Manser C., Tudor E.L., Lau K.F., Brownlees J., Ackerley S., Shaw P.J., Mcloughlin D.M., et al. Familial Amyotrophic Lateral Sclerosis-Linked SOD1 Mutants Perturb Fast Axonal Transport to Reduce Axonal Mitochondria Content. Hum. Mol. Genet. 2007;16:2720&#x2013;2728. doi: 10.1093/hmg/ddm226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm226</ArticleId><ArticleId IdType="pmc">PMC4516806</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., McDonald K.K., Boukhedimi Y., McAlonis-Downes M., Lobsiger C.S., Hadj S.B., Zandona A., Julien J.P., Shah S.B., Cleveland D.W. Misfolded SOD1 Associated with Motor Neuron Mitochondria Alters Mitochondrial Shape and Distribution Prior to Clinical Onset. PLoS ONE. 2011;6:e22031. doi: 10.1371/journal.pone.0022031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022031</ArticleId><ArticleId IdType="pmc">PMC3136936</ArticleId><ArticleId IdType="pubmed">21779368</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.B., Manfredi G. Abnormal Mitochondrial Transport and Morphology Are Common Pathological Denominators in SOD1 and TDP43 ALS Mouse Models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Gertz B., Pan Y., Price A.C., Molkentin J.D., Chang Q. The Mitochondrial Permeability Transition Pore in Motor Neurons: Involvement in the Pathobiology of ALS Mice. Exp. Neurol. 2009;218:333&#x2013;346. doi: 10.1016/j.expneurol.2009.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.02.015</ArticleId><ArticleId IdType="pmc">PMC2710399</ArticleId><ArticleId IdType="pubmed">19272377</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z., Wang W., Perry G., Zhu X., Wang X. Mitochondrial Dynamic Abnormalities in Amyotrophic Lateral Sclerosis. Transl. Neurodegener. 2015;4:14. doi: 10.1186/s40035-015-0037-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-015-0037-x</ArticleId><ArticleId IdType="pmc">PMC4518588</ArticleId><ArticleId IdType="pubmed">26225210</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn Superoxide Dismutase Gene Are Associated with Familial Amyotrophic Lateral Sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Groen E.J.N., Koppers M., Van Den Berg L.H., Pasterkamp R.J. Protein Aggregation in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.-M., Arzberger T., May S., Rentzsch K., Kremmer E., Schmid B. The C9orf72 GGGGC Repeat is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Julien J.P. Axonal Transport Deficits and Neurodegenerative Diseases. Nat. Rev. Neurosci. 2013;14:161&#x2013;176. doi: 10.1038/nrn3380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3380</ArticleId><ArticleId IdType="pubmed">23361386</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li A., Li X., Yi J. Dysregulated Mitochondrial Ca2+ and ROS Signaling in Skeletal Muscle of ALS Mouse Model. Arch. Biochem. Biophys. 2019;663:249&#x2013;258. doi: 10.1016/j.abb.2019.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2019.01.024</ArticleId><ArticleId IdType="pmc">PMC6506190</ArticleId><ArticleId IdType="pubmed">30682329</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemmerson R., Dubinsky J.M., Brustovetsky N. Cytochrome c Release from CNS Mitochondria and Potential for Clinical Intervention in Apoptosis-Mediated CNS Diseases. Antioxid. Redox Signal. 2005;7:1158&#x2013;1173. doi: 10.1089/ars.2005.7.1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2005.7.1158</ArticleId><ArticleId IdType="pubmed">16115019</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Bernhardi R., Eugen&#xed;n-von Bernhardi L., Eugen&#xed;n J. Microglial Cell Dysregulation in Brain Aging and Neurodegeneration. Front. Aging Neurosci. 2015;7:124. doi: 10.3389/fnagi.2015.00124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00124</ArticleId><ArticleId IdType="pmc">PMC4507468</ArticleId><ArticleId IdType="pubmed">26257642</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The Role of Mitochondria in Amyotrophic Lateral Sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya T., Maragkakis M. Amyotrophic Lateral Sclerosis Associated FUS Mutation Shortens Mitochondria and Induces Neurotoxicity. Sci. Rep. 2018;8:15575. doi: 10.1038/s41598-018-33964-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33964-0</ArticleId><ArticleId IdType="pmc">PMC6197261</ArticleId><ArticleId IdType="pubmed">30349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Moller A., Bauer C.S., Cohen R.N., Webster C.P., De Vos K.J. Amyotrophic Lateral Sclerosis-Associated Mutant SOD1 Inhibits Anterograde Axonal Transport of Mitochondria by Reducing Miro1 Levels. Hum. Mol. Genet. 2017;26:4668&#x2013;4679. doi: 10.1093/hmg/ddx348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx348</ArticleId><ArticleId IdType="pmc">PMC5886184</ArticleId><ArticleId IdType="pubmed">28973175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Jara J.H., Kocak N., Rylaarsdam L.E., Dong K., Bigio E.H., &#xd6;zdinler P.H. Mitochondria, ER, and Nuclear Membrane Defects Reveal Early Mechanisms for Upper Motor Neuron Vulnerability with Respect to TDP-43 Pathology. Acta Neuropathol. 2019;137:47&#x2013;69. doi: 10.1007/s00401-018-1934-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1934-8</ArticleId><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N. A Brief History of Autophagy from Cell Biology to Physiology and Disease. Nat. Cell Biol. 2018;20:521&#x2013;527. doi: 10.1038/s41556-018-0092-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0092-5</ArticleId><ArticleId IdType="pubmed">29686264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhang X., Song L., Le W. Autophagy Dysregulation in Amyotrophic Lateral Sclerosis. Brain Pathol. 2012;22:110&#x2013;116. doi: 10.1111/j.1750-3639.2011.00546.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2011.00546.x</ArticleId><ArticleId IdType="pubmed">22150926</ArticleId></ArticleIdList></Reference><Reference><Citation>Otomo A., Pan L., Hadano S. Dysregulation of the Autophagy-Endolysosomal System in Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases. Neurol. Res. Int. 2012;2012:498428. doi: 10.1155/2012/498428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/498428</ArticleId><ArticleId IdType="pmc">PMC3407648</ArticleId><ArticleId IdType="pubmed">22852081</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuspiel M., Schauss A.C., Braschi E., Zunino R., Rippstein P., Rachubinski R.A., Andrade-Navarro M.A., McBride H.M. Cargo-Selected Transport from the Mitochondria to Peroxisomes Is Mediated by Vesicular Carriers. Curr. Biol. 2008;18:102&#x2013;108. doi: 10.1016/j.cub.2007.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2007.12.038</ArticleId><ArticleId IdType="pubmed">18207745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao R.Q., Ren C., Xia Z.F., Yao Y.M. Organelle-Specific Autophagy in Inflammatory Diseases: A Potential Therapeutic Target Underlying the Quality Control of Multiple Organelles. Autophagy. 2020;12:1&#x2013;17. doi: 10.1080/15548627.2020.1725377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1725377</ArticleId><ArticleId IdType="pubmed">32048886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kundu M., Viollet B., Guan K.-L. AMPK and MTOR Regulate Autophagy through Direct Phosphorylation of Ulk1 Joungmok. Nat. Cell Biol. 2011;13:132&#x2013;141. doi: 10.1038/ncb2152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2152</ArticleId><ArticleId IdType="pmc">PMC3987946</ArticleId><ArticleId IdType="pubmed">21258367</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F.M., Fleming A., Caricasole A., Bento C.F., Andrews S.P., Ashkenazi A., F&#xfc;llgrabe J., Jackson A., Jimenez Sanchez M., Karabiyik C., et al. Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities. Neuron. 2017;93:1015&#x2013;1034. doi: 10.1016/j.neuron.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.01.022</ArticleId><ArticleId IdType="pubmed">28279350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Shin J.H., Lee J.E., Choi E.J. Role of Autophagy in the Pathogenesis of Amyotrophic Lateral Sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2015;1852:2517&#x2013;2524. doi: 10.1016/j.bbadis.2015.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.08.005</ArticleId><ArticleId IdType="pubmed">26264610</ArticleId></ArticleIdList></Reference><Reference><Citation>Fivenson E.M., Lautrup S., Sun N., Scheibye-Knudsen M., Stevnsner T., Nilsen H., Bohr V.A., Fang E.F. Mitophagy in Neurodegeneration and Aging. Neurochem. Int. 2017;109:202&#x2013;209. doi: 10.1016/j.neuint.2017.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.02.007</ArticleId><ArticleId IdType="pmc">PMC5565781</ArticleId><ArticleId IdType="pubmed">28235551</ArticleId></ArticleIdList></Reference><Reference><Citation>Granatiero V., Manfredi G. Mitochondrial Transport and Turnover in the Pathogenesis of Amyotrophic Lateral Sclerosis. Biology. 2019;8:36. doi: 10.3390/biology8020036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology8020036</ArticleId><ArticleId IdType="pmc">PMC6627920</ArticleId><ArticleId IdType="pubmed">31083575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C.W., Hang L., Yao T.P., Lim K.L. Parkin Regulation and Neurodegenerative Disorders. Front. Aging Neurosci. 2016;7:248. doi: 10.3389/fnagi.2015.00248.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00248</ArticleId><ArticleId IdType="pmc">PMC4709595</ArticleId><ArticleId IdType="pubmed">26793099</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Dorn G.W., 2nd PINK1- Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria. Science. 2013;340:471&#x2013;475. doi: 10.1126/science.1231031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1231031</ArticleId><ArticleId IdType="pmc">PMC3774525</ArticleId><ArticleId IdType="pubmed">23620051</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil R., Laplantine E., Curic S., G&#xe9;nin P. Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer. Front. Immunol. 2018;9:1243. doi: 10.3389/fimmu.2018.01243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01243</ArticleId><ArticleId IdType="pmc">PMC6018216</ArticleId><ArticleId IdType="pubmed">29971063</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes J.A., Davies M.C., Collins M.O. TBK1: A New Player in ALS Linking Autophagy and Neuroinflammation. Mol. Brain. 2017;10:5. doi: 10.1186/s13041-017-0287-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarou M., Sliter D.A., Kane L.A., Sarraf S.A., Wang C., Burman J.L., Sideris D.P., Fogel A.I., Youle R.J. The Ubiquitin Kinase PINK1 Recruits Autophagy Receptors to Induce Mitophagy. Nature. 2015;534:309&#x2013;314. doi: 10.1038/nature14893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14893</ArticleId><ArticleId IdType="pmc">PMC5018156</ArticleId><ArticleId IdType="pubmed">26266977</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez F.A., Palmiter R.D. Parkin-Deficient Mice Are Not a Robust Model of Parkinsonism. Proc. Natl. Acad. Sci. USA. 2005;102:2174&#x2013;2179. doi: 10.1073/pnas.0409598102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409598102</ArticleId><ArticleId IdType="pmc">PMC548311</ArticleId><ArticleId IdType="pubmed">15684050</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Grand J.N., Bon K., Fraichard A., Zhang J., Jouvenot M., Risold P.Y., Boyer-Guittaut M., Delage-Mourroux R. Specific Distribution of the Autophagic Protein GABARAPL1/GEC1 in the Developing and Adult Mouse Brain and Identification of Neuronal Populations Expressing GABARAPL1/GEC1. PLoS ONE. 2013;8:e63133. doi: 10.1371/journal.pone.0063133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063133</ArticleId><ArticleId IdType="pmc">PMC3655077</ArticleId><ArticleId IdType="pubmed">23690988</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa E., Marchetti S., Ricci J.E. No Parkin Zone: Mitophagy without Parkin. Trends Cell Biol. 2018;28:882&#x2013;895. doi: 10.1016/j.tcb.2018.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.07.004</ArticleId><ArticleId IdType="pubmed">30115557</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C.T. Mechanisms of Selective Autophagy and Mitophagy: Implications for Neurodegenerative Diseases. Neurobiol. Dis. 2019;122:23&#x2013;34. doi: 10.1016/j.nbd.2018.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.015</ArticleId><ArticleId IdType="pmc">PMC6396690</ArticleId><ArticleId IdType="pubmed">30030024</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.-C., Liang T.Y., Mazur C. Divergent Roles of ALS-Linked Proteins FUS/TLS and TDP-43 Intersect in Processing Long Pre-MRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo G.M., Granatiero V., Kawamata H., Konrad C., Kim M., Arreguin A.J., Zhao D., Milner T.A., Manfredi G. Parkin Is a Disease Modifier in the Mutant SOD 1 Mouse Model of ALS. EMBO Mol. Med. 2018;10:e8888. doi: 10.15252/emmm.201808888.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201808888</ArticleId><ArticleId IdType="pmc">PMC6180298</ArticleId><ArticleId IdType="pubmed">30126943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Deng J., Wang P., Yang M., Chen X., Zhu L., Liu J., Lu B., Shen Y., Fushimi K., et al. PINK1 and Parkin Are Genetic Modifiers for FUS-Induced Neurodegeneration. Hum. Mol. Genet. 2016;25:5059&#x2013;5068. doi: 10.1093/hmg/ddw310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw310</ArticleId><ArticleId IdType="pmc">PMC6078632</ArticleId><ArticleId IdType="pubmed">27794540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha S.J., Choi H.J., Kim H.J., Choi E.J., Song K.H., Im D.S., Kim K. Parkin Expression Reverses Mitochondrial Dysfunction in Fused in Sarcoma-Induced Amyotrophic Lateral Sclerosis. Insect Mol. Biol. 2020;29:56&#x2013;65. doi: 10.1111/imb.12608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imb.12608</ArticleId><ArticleId IdType="pubmed">31290213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Holzbaur E.L.F. Optineurin Is an Autophagy Receptor for Damaged Mitochondria in Parkin-Mediated Mitophagy That Is Disrupted by an ALS-Linked Mutation. Proc. Natl. Acad. Sci. USA. 2014;111:E4439&#x2013;E4448. doi: 10.1073/pnas.1405752111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1405752111</ArticleId><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirohi K., Swarup G. Defects in Autophagy Caused by Glaucoma-Associated Mutations in Optineurin. Exp. Eye Res. 2016;144:54&#x2013;63. doi: 10.1016/j.exer.2015.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exer.2015.08.020</ArticleId><ArticleId IdType="pubmed">26302410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak Y.J., Park J.H., Rhim H., Kang S. ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin. Int. J. Mol. Sci. 2020;21:7525. doi: 10.3390/ijms21207525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21207525</ArticleId><ArticleId IdType="pmc">PMC7590160</ArticleId><ArticleId IdType="pubmed">33065963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S., Mitsui S., Pan L., Otomo A., Kubo M., Sato K., Ono S., Onodera W., Abe K., Chen X.P., et al. Functional Links between SQSTM1 and ALS2 in the Pathogenesis of ALS: Cumulative Impact on the Protection against Mutant SOD1-Mediated Motor Dysfunction in Mice. Hum. Mol. Genet. 2016;25:3321&#x2013;3340. doi: 10.1093/hmg/ddw180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw180</ArticleId><ArticleId IdType="pubmed">27439389</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A.S., Holzbaur E.L.F. Dynamic Recruitment and Activation of ALS-Associated TBK1 with Its Target Optineurin Are Required for Efficient Mitophagy. Proc. Natl. Acad. Sci. USA. 2016;113:E3349&#x2013;E3358. doi: 10.1073/pnas.1523810113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1523810113</ArticleId><ArticleId IdType="pmc">PMC4914160</ArticleId><ArticleId IdType="pubmed">27247382</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D.K.H., Thombre R., Wang J. Autophagy as a Common Pathway in Amyotrophic Lateral Sclerosis. Neurosci. Lett. 2019;697:34&#x2013;48. doi: 10.1016/j.neulet.2018.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.006</ArticleId><ArticleId IdType="pmc">PMC6170747</ArticleId><ArticleId IdType="pubmed">29626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-Mediated ALS and FTD: Multiple Pathways to Disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Yan S., Zhang Z. Maintaining the Balance of TDP-43, Mitochondria, and Autophagy: A Promising Therapeutic Strategy for Neurodegenerative Diseases. Transl. Neurodegener. 2020;9:40. doi: 10.1186/s40035-020-00219-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00219-w</ArticleId><ArticleId IdType="pmc">PMC7597011</ArticleId><ArticleId IdType="pubmed">33126923</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Arakawa H., Wang L., Okolo O., Siedlak S.L., Jiang Y., Gao J., Xie F., Petersen R.B., Wang X. Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization. Mol. Ther. 2017;25:127&#x2013;139. doi: 10.1016/j.ymthe.2016.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2016.10.013</ArticleId><ArticleId IdType="pmc">PMC5363201</ArticleId><ArticleId IdType="pubmed">28129109</ArticleId></ArticleIdList></Reference><Reference><Citation>Akizuki M., Yamashita H., Uemura K., Maruyama H., Kawakami H., Ito H., Takahashi R. Optineurin Suppression Causes Neuronal Cell Death via NF-&#x39a;B Pathway. J. Neurochem. 2013;126:699&#x2013;704. doi: 10.1111/jnc.12326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12326</ArticleId><ArticleId IdType="pubmed">23721573</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa S., Oikawa D., Ishii R., Ayaki T., Takahashi H., Takeda H., Ishitani R., Kamei K., Takeyoshi I., Kawakami H., et al. Linear Ubiquitination Is Involved in the Pathogenesis of Optineurin-Associated Amyotrophic Lateral Sclerosis. Nat. Commun. 2016;7:12547. doi: 10.1038/ncomms12547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12547</ArticleId><ArticleId IdType="pmc">PMC4999505</ArticleId><ArticleId IdType="pubmed">27552911</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad L., Zhang S.-Y., Casanova J.-L., Sancho-Shimizu V. Human TBK1: A Gatekeeper of Neuroinflammation. Trends Mol. Med. 2016;22:511&#x2013;527. doi: 10.1016/j.molmed.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4890605</ArticleId><ArticleId IdType="pubmed">27211305</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E., Chi&#xf2; A., Inghilleri M., Mazzini L., Micheli A., Mora G., Poloni M. A Randomized Controlled Trial of Recombinant Interferon Beta-1a in ALS. Neurology. 2000;54:469&#x2013;474. doi: 10.1212/WNL.54.2.469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.2.469</ArticleId><ArticleId IdType="pubmed">10668716</ArticleId></ArticleIdList></Reference><Reference><Citation>Poutiainen E., Hokkanen L., Niemi M.L., F&#xe4;rkkil&#xe4; M. Reversible Cognitive Decline during High-Dose &#x3b1;-Interferon Treatment. Pharmacol. Biochem. Behav. 1994;47:901&#x2013;905. doi: 10.1016/0091-3057(94)90294-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0091-3057(94)90294-1</ArticleId><ArticleId IdType="pubmed">8029260</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Zhou X., Chang M., Nakaya M., Chang J.H., Xiao Y., William L.J., Dorta-Estremera S., Cao W., Zal A., et al. Regulation of T-Cell Activation and Migration by the Kinase TBK1 during Neuroinflammation. Nat. Commun. 2015;6:6074. doi: 10.1038/ncomms7074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7074</ArticleId><ArticleId IdType="pmc">PMC4302769</ArticleId><ArticleId IdType="pubmed">25606824</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., Jin T., Zhu H., Chen H., Ofengeim D., Zou C., Mifflin L., Pan L., Amin P., Li W., et al. TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging. Cell. 2018;174:1477&#x2013;1491. doi: 10.1016/j.cell.2018.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.041</ArticleId><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Autophagy in Spinal Cord Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2011;70:349&#x2013;359. doi: 10.1097/NEN.0b013e3182160690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182160690</ArticleId><ArticleId IdType="pubmed">21487309</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., et al. Suppression of Basal Autophagy in Neural Cells Causes Neurodegenerative Disease in Mice. Nature. 2006;441:885&#x2013;889. doi: 10.1038/nature04724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04724</ArticleId><ArticleId IdType="pubmed">16625204</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M., Waguri S., Chiba T., Murata S., Iwata J.I., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., et al. Loss of Autophagy in the Central Nervous System Causes Neurodegeneration in Mice. Nature. 2006;441:880&#x2013;884. doi: 10.1038/nature04723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04723</ArticleId><ArticleId IdType="pubmed">16625205</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A., Perera N.D., Beart P.M., Turner B.J., Shabanpoor F. Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting. Cells. 2020;9:2413. doi: 10.3390/cells9112413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112413</ArticleId><ArticleId IdType="pmc">PMC7694295</ArticleId><ArticleId IdType="pubmed">33158177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Chen S., Lu K., Wang F., Deng J., Xu Z., Wang X., Zhou Q., Le W., Zhao Y. Verapamil Ameliorates Motor Neuron Degeneration and Improves Lifespan in the SOD1G93A Mouse Model of Als by Enhancing Autophagic Flux. Aging Dis. 2019;10:1159&#x2013;1173. doi: 10.14336/AD.2019.0228.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2019.0228</ArticleId><ArticleId IdType="pmc">PMC6844595</ArticleId><ArticleId IdType="pubmed">31788329</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H., Lee J.H. Calcium Channel Blockers as Potential Therapeutics for Obesity-Associated Autophagy Defects and Fatty Liver Pathologies. Autophagy. 2014;10:2385&#x2013;2386. doi: 10.4161/15548627.2014.984268.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/15548627.2014.984268</ArticleId><ArticleId IdType="pmc">PMC4502701</ArticleId><ArticleId IdType="pubmed">25484079</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera N.D., Sheean R.K., Lau C.L., Shin Y.S., Beart P.M., Horne M.K., Turner B.J. Rilmenidine Promotes MTOR-Independent Autophagy in the Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis without Slowing Disease Progression. Autophagy. 2018;14:534&#x2013;551. doi: 10.1080/15548627.2017.1385674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1385674</ArticleId><ArticleId IdType="pmc">PMC5915012</ArticleId><ArticleId IdType="pubmed">28980850</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Fabbrizio P., Amadio S., Volont&#xe9; C. Actions of the Antihistaminergic Clemastine on Presymptomatic SOD1-G93A Mice Ameliorate ALS Disease Progression. J. Neuroinflamm. 2016;13:191. doi: 10.1186/s12974-016-0658-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0658-8</ArticleId><ArticleId IdType="pmc">PMC4994328</ArticleId><ArticleId IdType="pubmed">27549088</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo K., Nassif M., Valenzuela V., Rojas F., Matus S., Mercado G., Court F.A., Van Zundert B., Hetz C. Trehalose Delays the Progression of Amyotrophic Lateral Sclerosis by Enhancing Autophagy in Motoneurons. Autophagy. 2013;9:1308&#x2013;1320. doi: 10.4161/auto.25188.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.25188</ArticleId><ArticleId IdType="pubmed">23851366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Chen S., Song L., Tang Y., Shen Y., Jia L., Le W. MTOR-Independent, Autophagic Enhancer Trehalose Prolongs Motor Neuron Survival and Ameliorates the Autophagic Flux Defect in a Mouse Model of Amyotrophic Lateral Sclerosis. Autophagy. 2014;10:588&#x2013;602. doi: 10.4161/auto.27710.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.27710</ArticleId><ArticleId IdType="pmc">PMC4091147</ArticleId><ArticleId IdType="pubmed">24441414</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Guo Y., Wang X., Yu X., Duan W., Hong K., Wang J., Han H., Li C. Trehalose Decreases Mutant SOD1 Expression and Alleviates Motor Deficiency in Early but Not End-Stage Amyotrophic Lateral Sclerosis in a SOD1-G93A Mouse Model. Neuroscience. 2015;298:12&#x2013;25. doi: 10.1016/j.neuroscience.2015.03.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.03.061</ArticleId><ArticleId IdType="pubmed">25841320</ArticleId></ArticleIdList></Reference><Reference><Citation>Thau N., Knippenberg S., K&#xf6;rner S., Rath K.J., Dengler R., Petri S. Decreased MRNA Expression of PGC-1&#x3b1; and PGC-1&#x3b1;regulated Factors in the SOD1G93A ALS Mouse Model and in Human Sporadic ALS. J. Neuropathol. Exp. Neurol. 2012;71:1064&#x2013;1074. doi: 10.1097/NEN.0b013e318275df4b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318275df4b</ArticleId><ArticleId IdType="pubmed">23147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Zhou B., Lin M.-Y., Wang S., Foust K.D., Sheng Z.-H. Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic FALS Mice. Neuron. 2015;87:355&#x2013;370. doi: 10.1016/j.neuron.2015.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.06.026</ArticleId><ArticleId IdType="pmc">PMC4511489</ArticleId><ArticleId IdType="pubmed">26182418</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C.S., Holzbaur E.L.F. Lysosomal Degradation of Depolarized Mitochondria Is Rate-Limiting in OPTN-Dependent Neuronal Mitophagy. Autophagy. 2020;16:962&#x2013;964. doi: 10.1080/15548627.2020.1734330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1734330</ArticleId><ArticleId IdType="pmc">PMC7144876</ArticleId><ArticleId IdType="pubmed">32131674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornai F., Longone P., Cafaro L., Kastsiuchenka O., Ferrucci M., Manca M.L., Lazzeri G., Spalloni A., Bellio N., Lenzi P., et al. Lithium Delays Progression of Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2008;105:2052&#x2013;2057. doi: 10.1073/pnas.0708022105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0708022105</ArticleId><ArticleId IdType="pmc">PMC2538879</ArticleId><ArticleId IdType="pubmed">18250315</ArticleId></ArticleIdList></Reference><Reference><Citation>Meira Martins L.A., Vieira M.Q., Ilha M., de Vasconcelos M., Biehl H.B., Lima D.B., Schein V., Barb&#xe9;-Tuana F., Borojevic R., Guma F.C.R. The Interplay Between Apoptosis, Mitophagy and Mitochondrial Biogenesis Induced by Resveratrol Can Determine Activated Hepatic Stellate Cells Death or Survival. Cell Biochem. Biophys. 2014;71:657&#x2013;672. doi: 10.1007/s12013-014-0245-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-014-0245-5</ArticleId><ArticleId IdType="pubmed">25234614</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S., Parone P.A., Lopes V.S., Lillo C., McAlonis-Downes M., Lee S.K., Vetto A.P., Petrosyan S., Marsala M., Murphy A.N., et al. Elevated PGC-1&#x3b1; Activity Sustains Mitochondrial Biogenesis and Muscle Function without Extending Survival in a Mouse Model of Inherited ALS. Cell Metab. 2012;15:778&#x2013;786. doi: 10.1016/j.cmet.2012.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.03.019</ArticleId><ArticleId IdType="pmc">PMC3565468</ArticleId><ArticleId IdType="pubmed">22560226</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark J.A., Southam K.A., Blizzard C.A., King A.E., Dickson T.C. Axonal Degeneration, Distal Collateral Branching and Neuromuscular Junction Architecture Alterations Occur Prior to Symptom Onset in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. J. Chem. Neuroanat. 2016;76:35&#x2013;47. doi: 10.1016/j.jchemneu.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau &#xc9;., Di Polo A., Velde C.V., Robitaille R. Dynamic Neuromuscular Remodeling Precedes Motor-Unit Loss in a Mouse Model of ALS. eLife. 2018;7:e41973. doi: 10.7554/eLife.41973.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41973</ArticleId><ArticleId IdType="pmc">PMC6234026</ArticleId><ArticleId IdType="pubmed">30320556</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick N.D., Griffey C.J., Guarnieri P., Gerbino V., Wang X., Piersaint J.A., Tapia J.C., Rich M.M., Maniatis T. Distinct Roles for Motor Neuron Autophagy Early and Late in the SOD1G93A Mouse Model of ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E8294&#x2013;E8303. doi: 10.1073/pnas.1704294114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanning K.C., Kaplan A., Henderson C.E. Motor Neuron Diversity in Development and Disease. Annu. Rev. Neurosci. 2010;33:409&#x2013;440. doi: 10.1146/annurev.neuro.051508.135722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.051508.135722</ArticleId><ArticleId IdType="pubmed">20367447</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Masson G., Przedborski S., Abbott L.F. A Computational Model of Motor Neuron Degeneration. Neuron. 2014;83:975&#x2013;988. doi: 10.1016/j.neuron.2014.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.07.001</ArticleId><ArticleId IdType="pmc">PMC4167823</ArticleId><ArticleId IdType="pubmed">25088365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Bonifacino T., Bartolucci M., Milanese M., Gallia E., Provenzano F., Cortese K., Panfoli I., Bonanno G. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2018;55:9220&#x2013;9233. doi: 10.1007/s12035-018-1059-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1059-z</ArticleId><ArticleId IdType="pubmed">29656361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Torazza C., Bonifacino T., Provenzano F., Rebosio C., Milanese M., Usai C., Panfoli I., Bonanno G. Altered Glucose Catabolism in the Presynaptic and Perisynaptic Compartments of SOD1G93A Mouse Spinal Cord and Motor Cortex Indicates That Mitochondria Are the Site of Bioenergetic Imbalance in ALS. J. Neurochem. 2019;151:336&#x2013;350. doi: 10.1111/jnc.14819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14819</ArticleId><ArticleId IdType="pubmed">31282572</ArticleId></ArticleIdList></Reference><Reference><Citation>Purves D., Augustine G.J., Fitzpatrick D., Katz L.C., LaMantia A.-S., McNamara J.O., Williams M. Neuroscience. 2nd ed. Sinauer Associates; Sunderland, UK: 2001.</Citation></Reference><Reference><Citation>Rogers R.S., Tungtur S., Tanaka T., Nadeau L.L., Badawi Y., Wang H., Ni H.M., Ding W.X., Nishimune H. Impaired Mitophagy Plays a Role in Denervation of Neuromuscular Junctions in ALS Mice. Front. Neurosci. 2017;11:447. doi: 10.3389/fnins.2017.00473.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00473</ArticleId><ArticleId IdType="pmc">PMC5575151</ArticleId><ArticleId IdType="pubmed">28890682</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor Neuron Vulnerability and Resistance in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium Dysregulation in Amyotrophic Lateral Sclerosis. Cell Calcium. 2010;47:165&#x2013;174. doi: 10.1016/j.ceca.2009.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.12.002</ArticleId><ArticleId IdType="pubmed">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett E.F., Barrett J.N., David G. Dysfunctional Mitochondrial Ca2+ Handling in Mutant SOD1 Mouse Models of FALS: Integration of Findings from Motor Neuron Somata and Motor Terminals. Front. Cell. Neurosci. 2014;8:184. doi: 10.3389/fncel.2014.00184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00184</ArticleId><ArticleId IdType="pmc">PMC4085874</ArticleId><ArticleId IdType="pubmed">25071445</ArticleId></ArticleIdList></Reference><Reference><Citation>Strohm L., Behrends C. Glia-Specific Autophagy Dysfunction in ALS. Semin. Cell Dev. Biol. 2020;99:172&#x2013;182. doi: 10.1016/j.semcdb.2019.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.024</ArticleId><ArticleId IdType="pubmed">31132469</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-Type Microglia Extend Survival in PU.1 Knockout Mice with Familial Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2006;103:16021&#x2013;16026. doi: 10.1073/pnas.0607423103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as Determinants of Disease Progression in Inherited Amyotrophic Lateral Sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Sieverding K., Bruno C., L&#xfc;ningschr&#xf6;r P., Buck E., Mungwa S., Fischer L., Brockmann S.J., Ulmer J., Bliederh&#xe4;user C., et al. Heterozygous Tbk1 Loss Has Opposing Effects in Early and Late Stages of ALS in Mice. J. Exp. Med. 2019;216:267&#x2013;278. doi: 10.1084/jem.20180729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180729</ArticleId><ArticleId IdType="pmc">PMC6363427</ArticleId><ArticleId IdType="pubmed">30635357</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V., Kaunga E., Ye J., Canzio D., O&#x2019;Keeffe S., Rudnick N.D., Guarnieri P., Lutz C.M., Maniatis T. The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice. Neuron. 2020;106:789&#x2013;805.e5. doi: 10.1016/j.neuron.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.03.005</ArticleId><ArticleId IdType="pubmed">32220666</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Lee J.W., Nam H., Yu S.W., Yu S.W. Cx3cr1 CreERT2-Driven Atg7 Deletion in Adult Mice Induces Intestinal Adhesion. Mol. Brain. 2020;13:88. doi: 10.1186/s13041-020-00630-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-00630-4</ArticleId><ArticleId IdType="pmc">PMC7281947</ArticleId><ArticleId IdType="pubmed">32513210</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautrup S., Lou G., Aman Y., Nilsen H., Tao J., Fang E.F. Microglial Mitophagy Mitigates Neuroinflammation in Alzheimer&#x2019;s Disease. Neurochem. Int. 2019;129:104469. doi: 10.1016/j.neuint.2019.104469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.104469</ArticleId><ArticleId IdType="pubmed">31100304</ArticleId></ArticleIdList></Reference><Reference><Citation>Choong C.-J., Okuno T., Ikenaka K., Baba K., Hayakawa H., Koike M., Yokota M., Doi J., Kakuda K., Takeuchi T., et al. Alternative Mitochondrial Quality Control Mediated by Extracellular Release. Autophagy. 2020:1&#x2013;13. doi: 10.1080/15548627.2020.1848130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1848130</ArticleId><ArticleId IdType="pubmed">33218272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwa E., Pointer C.B., Klegeris A. The Role of Mitochondrial Damage-Associated Molecular Patterns in Chronic Neuroinflammation. Mediat. Inflamm. 2019;2019:4050796. doi: 10.1155/2019/4050796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4050796</ArticleId><ArticleId IdType="pmc">PMC6466851</ArticleId><ArticleId IdType="pubmed">31065234</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales I., Sanchez A., Puertas-Avenda&#xf1;o R., Rodriguez-Sabate C., Perez-Barreto A., Rodriguez M. Neuroglial Transmitophagy and Parkinson&#x2019;s Disease. Glia. 2020;68:2277&#x2013;2299.</Citation><ArticleIdList><ArticleId IdType="pubmed">32415886</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson J.G., Robinson M.B. Regulation of Mitochondrial Dynamics in Astrocytes: Mechanisms, Consequences, and Unknowns. Glia. 2018;66:1213&#x2013;1234. doi: 10.1002/glia.23252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23252</ArticleId><ArticleId IdType="pmc">PMC5904024</ArticleId><ArticleId IdType="pubmed">29098734</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaza-Zabala A., Sierra-Torre V., Sierra A. Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging. Int. J. Mol. Sci. 2017;18:598. doi: 10.3390/ijms18030598.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18030598</ArticleId><ArticleId IdType="pmc">PMC5372614</ArticleId><ArticleId IdType="pubmed">28282924</ArticleId></ArticleIdList></Reference><Reference><Citation>Berglund R., Guerreiro-Cacais A.O., Adzemovic M.Z., Zeitelhofer M., Lund H., Ewing E., Ruhrmann S., Nutma E., Parsa R., Thessen-Hedreul M., et al. Microglial Autophagy-Associated Phagocytosis Is Essential for Recovery from Neuroinflammation. Sci. Immunol. 2020;5:eabb5077. doi: 10.1126/sciimmunol.abb5077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abb5077</ArticleId><ArticleId IdType="pubmed">33067381</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz C. Mouse Models of ALS: Past, Present and Future. Brain Res. 2018;1693:1&#x2013;10. doi: 10.1016/j.brainres.2018.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.03.024</ArticleId><ArticleId IdType="pubmed">29577886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieverding K., Ulmer J., Bruno C., Satoh T., Tsao W., Freischmidt A., Akira S., Wong P.C., Ludolph A.C., Danzer K.M., et al. Hemizygous Deletion of Tbk1 Worsens Neuromuscular Junction Pathology in TDP-43G298S Transgenic Mice. Exp. Neurol. 2020;335:113496. doi: 10.1016/j.expneurol.2020.113496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113496</ArticleId><ArticleId IdType="pubmed">33038415</ArticleId></ArticleIdList></Reference><Reference><Citation>Shellikeri S., Karthikeyan V., Martino R., Black S.E., Zinman L., Keith J., Yunusova Y. The Neuropathological Signature of Bulbar-Onset ALS: A Systematic Review. Neurosci. Biobehav. Rev. 2017;75:378&#x2013;392. doi: 10.1016/j.neubiorev.2017.01.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.01.045</ArticleId><ArticleId IdType="pmc">PMC5425954</ArticleId><ArticleId IdType="pubmed">28163193</ArticleId></ArticleIdList></Reference><Reference><Citation>Smittkamp S.E., Spalding H.N., Brown J.W., Gupte A.A., Chen J., Nishimune H., Geiger P.C., Stanford J.A. Measures of Bulbar and Spinal Motor Function, Muscle Innervation, and Mitochondrial Function in ALS Rats. Behav. Brain Res. 2010;211:48&#x2013;57. doi: 10.1016/j.bbr.2010.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2010.03.007</ArticleId><ArticleId IdType="pmc">PMC2872192</ArticleId><ArticleId IdType="pubmed">20211206</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi E., Orioli E., Dal Ben D., Adinolfi E. P2X7 Receptor as a Therapeutic Target. Adv. Protein Chem. Struct. Biol. 2016;104:39&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">27038372</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbrizio P., Amadio S., Apolloni S., Volont&#xe9; C. P2X7 Receptor Activation Modulates Autophagy in SOD1-G93a Mouse Microglia. Front. Cell. Neurosci. 2017;11:249. doi: 10.3389/fncel.2017.00249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00249</ArticleId><ArticleId IdType="pmc">PMC5566572</ArticleId><ArticleId IdType="pubmed">28871219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekar P., Huang D.Y., Hsieh S.L., Chang S.F., Lin W.W. AMPK-Dependent and Independent Actions of P2X7 in Regulation of Mitochondrial and Lysosomal Functions in Microglia. Cell Commun. Signal. 2018;16:83. doi: 10.1186/s12964-018-0293-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-018-0293-3</ArticleId><ArticleId IdType="pmc">PMC6245559</ArticleId><ArticleId IdType="pubmed">30458799</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>